HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichi Honke Selected Research

Fucose

11/2005Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice.
10/2003Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
11/2002An enzymatic method of analysis for GDP-L-fucose in biological samples, involving high-performance liquid chromatography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichi Honke Research Topics

Disease

18Neoplasms (Cancer)
12/2021 - 08/2002
5Hepatocellular Carcinoma (Hepatoma)
11/2005 - 08/2002
4Inflammation (Inflammations)
01/2013 - 03/2002
4Emphysema
05/2007 - 11/2005
4Neoplasm Metastasis (Metastasis)
04/2006 - 05/2002
3Melanoma (Melanoma, Malignant)
12/2021 - 11/2012
3Colonic Neoplasms (Colon Cancer)
09/2009 - 04/2006
2Lung Neoplasms (Lung Cancer)
01/2021 - 08/2019
2Glioma (Gliomas)
01/2020 - 06/2015
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2019 - 11/2003
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2012 - 05/2010
2Infections
06/2008 - 11/2002
2Ureteral Obstruction
01/2004 - 01/2004
2Atherosclerosis
02/2003 - 03/2002
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
02/2014
1Demyelinating Diseases (Demyelinating Disease)
06/2013
1Lymphoma (Lymphomas)
10/2012
1Colorectal Neoplasms (Colorectal Cancer)
09/2009
1Thrombosis (Thrombus)
03/2008
1Acinar Cell Carcinoma
10/2006
1Leukemia
11/2005
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2005
1Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency
01/2005
1Nervous System Diseases (Neurological Disorders)
01/2004

Drug/Important Bio-Agent (IBA)

6OligosaccharidesIBA
01/2020 - 05/2002
6Glycoproteins (Glycoprotein)IBA
10/2006 - 05/2002
4EnzymesIBA
12/2021 - 01/2016
4Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2002
4Polysaccharides (Glycans)IBA
06/2013 - 07/2003
3IntegrinsIBA
12/2021 - 01/2018
3GD3 ganglioside (GD(3))IBA
01/2016 - 11/2012
3Sulfoglycosphingolipids (Sulfatides)IBA
01/2013 - 01/2004
3L-SelectinIBA
01/2013 - 01/2004
3Biological ProductsIBA
09/2009 - 05/2002
3Matrix Metalloproteinases (MMPs)IBA
04/2006 - 11/2005
3FucoseIBA
11/2005 - 11/2002
2GangliosidesIBA
12/2021 - 06/2015
2GD2 gangliosideIBA
12/2021 - 01/2018
2Lactic Acid (Lactate)FDA LinkGeneric
01/2020 - 02/2014
2Small Interfering RNA (siRNA)IBA
01/2020 - 02/2014
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2020 - 02/2014
2ChitosanIBA
01/2020 - 02/2014
2AntigensIBA
08/2019 - 05/2010
2GlycolipidsIBA
06/2015 - 01/2004
2Phosphotransferases (Kinase)IBA
06/2015 - 05/2010
2LigandsIBA
01/2013 - 01/2004
2Rituximab (Mabthera)FDA Link
10/2012 - 05/2010
2Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
05/2007 - 10/2006
2Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2006 - 11/2005
2LectinsIBA
11/2005 - 08/2002
2matriptaseIBA
02/2004 - 05/2002
2Guanosine Diphosphate (GDP)IBA
10/2003 - 11/2002
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2020
1Therapeutic UsesIBA
01/2020
1Indicators and Reagents (Reagents)IBA
08/2019
1Fibroblast Growth Factor 3IBA
08/2019
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Angiogenesis InhibitorsIBA
01/2018
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2018
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2016
1neogeninIBA
01/2016
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
06/2015
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
06/2015
1Ethylene Glycol (Monoethylene Glycol)IBA
02/2014
1CuprizoneIBA
06/2013
1CD20 AntigensIBA
10/2012
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
10/2012
1LipidsIBA
05/2010
1GlycoconjugatesIBA
05/2010
1tyrosine receptor (receptor, tyrosine)IBA
05/2010
1Surface Antigens (Surface Antigen)IBA
05/2010
1Monoclonal AntibodiesIBA
05/2010
1Galactose (Galactopyranose)FDA LinkGeneric
09/2009
1CarbohydratesIBA
09/2009
1GlycosphingolipidsIBA
09/2009
1AminopyridinesIBA
09/2009
1CollagenIBA
03/2008
1Epidermal Growth Factor (EGF)IBA
05/2007
1GlycosyltransferasesIBA
10/2006
1Peptides (Polypeptides)IBA
10/2006
1PhytohemagglutininsIBA
05/2006
1Matrix Metalloproteinase 7 (Matrilysin)IBA
04/2006
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2006
1cholesteryl sulfateIBA
04/2006
1betadex (beta-cyclodextrin)IBA
04/2006
1ElastinIBA
01/2006
1N-Acetylneuraminic Acid (Sialic Acid)IBA
11/2005
1Xanthine OxidaseIBA
11/2005
1Annexin A5IBA
11/2005
1HypoxanthineIBA
11/2005
1SteroidsIBA
01/2005
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2005
1Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
01/2005
1VitronectinIBA
07/2004
1Integrin alphaVbeta3IBA
07/2004
1alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
02/2004
1galactosylceramide sulfotransferaseIBA
01/2004

Therapy/Procedure

2Therapeutics
01/2020 - 08/2019